Subjective impressions of stable patients with paranoid schizophrenia after adding to antipsychotic treatment anticholinesterase agent.

被引：0
|
作者：
Morozova, M. [1 ]
Rupchev, G. [1 ]
机构：
[1] Fed State Budgetary Sci Inst Mental Hlth Res Ctr, Lab Psychopharmacol, Moscow, Russia
来源：
EUROPEAN PSYCHIATRY | 2020年 / 63卷
关键词：
schizophrenia; negative symptoms; add-on treatment; ipidacrine;
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
EPP1111
引用
收藏
页码：S249 / S250
页数：2
相关论文
共 50 条
  • [31] Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment
    Pirildar, S
    Gönül, AS
    Taneli, F
    Akdeniz, F
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2004, 28 (04): : 709 - 713
  • [32] Status of plasma nitric oxide and non-enzymatic antioxidants before and after antipsychotic treatment in Nigerian patients with schizophrenia
    Arinola, O. G.
    Idonije, O. B.
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2009, 14 (01): : 37 - 42
  • [33] THE COMPARISON OF β-ENDORPHIN AND CGRP LEVELS IN PATIENTS WITH SEVERE SYMPTOMS OF SCHIZOPHRENIA AND IN STABLE MENTAL STATE AFTER TREATMENT
    Urban-Kowalczyk, M.
    Smigielski, J.
    Rabe-Jablonska, J.
    EUROPEAN PSYCHIATRY, 2013, 28
  • [34] Cytokine alterations in first-episode schizophrenia patients before and after antipsychotic treatment (vol 154, pg 23, 2014)
    de Witte, Lot
    Tomasik, Jakub
    Schwarz, Emanuel
    Guest, Paul C.
    Rahmoune, Hassan
    Steiner, Johann
    Rothermundt, Matthias
    Leweke, F. Markus
    van Beveren, Nico J.
    Kahn, Rene S.
    Bahn, Sabine
    SCHIZOPHRENIA RESEARCH, 2014, 157 (1-3) : 321 - 321
  • [35] Auditing Clinical Outcomes after Introducing Off-Licence Prescribing of Atypical Antipsychotic Melperone for Patients with Treatment Refractory Schizophrenia
    Roehricht, Frank
    Gadhia, Seema
    Alam, Rinku
    Willis, Melissa
    SCIENTIFIC WORLD JOURNAL, 2012,
  • [36] WORKING MEMORY-RELATED BRAIN ACTIVITY IN ANTIPSYCHOTIC-NAIVE SCHIZOPHRENIA PATIENTS AFTER SEVEN MONTHS OF QUETIAPINE TREATMENT
    Nejad, Ayna B.
    Ebdrup, Bjorn H.
    Rasmussen, Hans
    Aggernaes, Bodil
    Baare, William F. C.
    Siebner, Hartwig R.
    Glenthoj, Birte Y.
    SCHIZOPHRENIA RESEARCH, 2012, 136 : S197 - S197
  • [37] Widespread white-matter microstructure integrity reduction in first-episode schizophrenia patients after acute antipsychotic treatment
    Meng, Linghui
    Li, Kaiming
    Li, Wenbin
    Xiao, Yuan
    Lui, Su
    Sweeney, John A.
    Gong, Qiyong
    SCHIZOPHRENIA RESEARCH, 2019, 204 : 238 - 244
  • [38] Extrastriatal dopamine D2/3 receptors and cortical grey matter volumes in antipsychotic-naive schizophrenia patients before and after initial antipsychotic treatment
    Norbak-Emig, Henrik
    Pinborg, Lars H.
    Raghava, Jayachandra M.
    Svarer, Claus
    Baare, William F. C.
    Allerup, Peter
    Friberg, Lars
    Rostrup, Egill
    Glenthoj, Birte
    Ebdrup, Bjorn H.
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2017, 18 (07): : 539 - 549
  • [39] The effects of adding long-acting injectable antipsychotic drugs to clozapine on relapse and hospitalization in patients with treatment-resistant schizophrenia: a mirror-image retrospective study
    Caliskan, Ali Metehan
    Karaaslan, Munir
    Inanli, Ikbal
    Caliskan, Sila
    Arslan, Mehmet
    Cicek, Ismet Esra
    Eren, Ibrahim
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2021, 36 (01) : 30 - 33
  • [40] Abnormal white matter microstructure in drug-naive first episode schizophrenia patients before and after eight weeks of antipsychotic treatment
    Zeng, Botao
    Ardekani, Babak A.
    Tang, Yingying
    Zhang, Tianhong
    Zhao, Shanshan
    Cui, Huiru
    Fan, Xiaoduo
    Zhuo, Kaiming
    Li, Chunbo
    Xu, Yifeng
    Goff, Donald C.
    Wang, Jijun
    SCHIZOPHRENIA RESEARCH, 2016, 172 (1-3) : 1 - 8
12345